Clinical features of hepatitis B virus-related hepatocellular carcinoma

被引：33
作者：
Ishikawa, Toru [1 ]
机构：
[1] Saiseikai Niigata Second Hosp, Dept Gastroenterol & Hepatol, Niigata 9501104, Japan
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2010年 / 16卷 / 20期
关键词：
Hepatocellular carcinoma; Hepatitis B virus; LIVER RESECTION; INTERFERON; RECURRENCE; LAMIVUDINE; CIRRHOSIS; SURVIVAL; INFECTION; THERAPY; INTEGRATION; ABLATION;
D O I：
10.3748/wjg.v16.i20.2463
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Hepatocellular carcinoma (HCC) is a major cause of cancer death, and chronic hepatitis B is a serious worldwide problem. The epidemiology of HCC is distinctive. Hepatitis B virus (HBV) plays a major role in hepatocarcinogenesis. Prevention of HBV-related HCC is a key issue in current hepatology. This paper describes the prevention and clinical features of HBV-related HCC, along with a short review of the disease. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码：2463 / 2467
页数：5
相关论文
共 28 条
  • [1] Ikeda K, 1998, CANCER-AM CANCER SOC, V82, P827, DOI 10.1002/(SICI)1097-0142(19980301)82:5<827::AID-CNCR5>3.0.CO
  • [2] 2-G
  • [3] High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis
    Ishikawa, T
    Ichida, T
    Yamagiwa, S
    Sugahara, S
    Uehara, K
    Okoshi, S
    Asakura, H
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (11) : 1274 - 1281
  • [4] Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients
    Ishikawa, Toru
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (40) : 6140 - 6144
  • [5] Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: A pilot study
    Ishikawa, Toru
    Imai, Michitaka
    Kamimura, Hiroteru
    Tsuchiya, Atsunori
    Togashi, Tadayuki
    Watanabe, Kouji
    Seki, Kei-ichi
    Ohta, Hironobu
    Yoshida, Toshiaki
    Kamimura, Tomoteru
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (41) : 5465 - 5470
  • [6] The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization - Implications for viral suppression to reduce the risk oil cancer recurrence
    Jang, Jeong Won
    Choi, Jong Young
    Bae, Si Hyun
    Yoon, Seung Kew
    Woo, Hyun Young
    Chang, U. Im
    Kim, Chang Wook
    Nam, Soon Woo
    Cho, Se Hyun
    Yang, Jin Mo
    Lee, Chang Don
    [J]. CANCER, 2007, 110 (08) : 1760 - 1767
  • [7] Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus - An analysis of 236 consecutive patients with a single lesion
    Koike, Y
    Shiratori, Y
    Sato, S
    Obi, S
    Teratani, T
    Imamura, M
    Hamamura, K
    Imai, Y
    Yoshida, H
    Shiina, S
    Omata, M
    [J]. HEPATOLOGY, 2000, 32 (06) : 1216 - 1223
  • [8] Kubo S, 2000, CANCER-AM CANCER SOC, V88, P1016, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO
  • [9] 2-V
  • [10] Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B
    Kubo, S
    Hirohashi, K
    Yamazaki, O
    Matsuyama, M
    Tanaka, H
    Horii, K
    Shuto, T
    Yamamoto, T
    Kawai, S
    Wakasa, K
    Nishiguchi, S
    Kinoshita, H
    [J]. WORLD JOURNAL OF SURGERY, 2002, 26 (05) : 555 - 560
123